Home/Pipeline/AlphaSTEM Test®

AlphaSTEM Test®

Evaluation of Stem Cell Toxicity in Drug Development

Service/DiagnosticAvailable

Key Facts

Indication
Evaluation of Stem Cell Toxicity in Drug Development
Phase
Service/Diagnostic
Status
Available
Company

About Asymmetrex

Asymmetrex's mission is to solve the long-standing problem of counting tissue stem cells, a fundamental barrier in stem cell biology and medicine. The company's proprietary Kinetic Stem Cell Counting technology provides a functional assay to determine the number and concentration of therapeutic stem cells, which is critical for standardizing stem cell transplantation, manufacturing, and drug testing. By enabling precise stem cell dosage, Asymmetrex aims to improve the safety, efficacy, and commercialization of stem cell therapies and accelerate pharmaceutical development. The company operates as a private entity, leveraging its platform through research collaborations, service offerings, and technology licensing.

View full company profile